Figure 1From: Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study Western-blot analysis of saliva levels of gelsolin (a) and transthyretin (b) in AD and control groups (n = 41-44 per group). Figures shows representative blots and quantitative from 4 independent measurements.Back to article page